Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.330
-0.040 (-2.92%)
Jul 22, 2025, 3:56 PM HKT
11.76%
Market Cap2.06B
Revenue (ttm)1.13B
Net Income (ttm)601.19M
Shares Out1.50B
EPS (ttm)0.40
PE Ratio3.43
Forward PEn/a
Dividend0.06 (4.60%)
Ex-Dividend DateMay 27, 2025
Volume340,000
Average Volume6,006,665
Open1.370
Previous Close1.370
Day's Range1.320 - 1.380
52-Week Range1.070 - 1.470
Beta0.67
RSI68.15
Earnings DateAug 22, 2025

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates through two segments, Intermediates and Bulk Medicines; and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines comprising cardiovascular systems; anti-HBV, anti-all... [Read more]

Sector Healthcare
Founded 1995
Employees 1,183
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2348
Full Company Profile

Financial Performance

In 2024, HKG:2348's revenue was 1.06 billion, a decrease of -7.89% compared to the previous year's 1.15 billion. Earnings were 564.94 million, an increase of 73.29%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.